Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology

Rhea-AI Summary

Royal Philips (NYSE: PHG) on November 19, 2025 announced an extended partnership with Cortechs.ai to integrate Cortechs.ai’s AI-enabled NeuroQuant quantitative neuroimaging analytics into Philips MR workflows.

The companies plan to embed brain volumetrics, lesion quantification and tumor tracking into Philips MR systems via the cloud-based Smart Reading environment to deliver automated, zero-click quantitative reports to clinicians, aiming to improve speed, reproducibility and diagnostic confidence while addressing radiology workforce pressures.

NeuroQuant is currently available on Philips Advanced Visualization Workspace; Smart Reading integration is a work in progress and not yet available in any jurisdiction.

Insights

Healthcare technology strategist

Extended Philips–Cortechs.ai partnership integrates quantitative neuroimaging into MR workflows, aiming to standardize and speed neurological diagnoses.

Combining Philips MR systems with Cortechs.ai’s NeuroQuant® embeds AI-driven volumetrics, lesion quantification, and tumor tracking into imaging workflows to deliver numerical biomarkers alongside images.

Benefits depend on deployment and regulatory availability; the release notes the integration is a work in progress and not yet available in any jurisdiction, while NeuroQuant® remains available via Advanced Visualization Workspace.

Watch for clinical validation, regulatory clearances, and site rollouts over the next 6–24 months; a near-term signpost is broader availability beyond Advanced Visualization Workspace following completion of the Smart Reading integration.

Clinical radiology workflow expert

The integration aims to reduce manual post-processing and provide zero-click quantitative reports inside MR/PACS workflows.

Embedding Cortechs.ai analytics into Philips’ Smart Reading intends to deliver automated, quality-checked reports directly on the MR system or PACS, which could reduce technologist steps and improve report consistency.

Operational impact hinges on seamless PACS/MR integration, validation of automated outputs, and local workflow adoption; the statement explicitly says the Smart Reading integration is a work in progress and not universally available.

Key near-term items to monitor include completion of the Smart Reading build, formal availability dates, and any published performance/validation data; also note that up to 25% of MR procedures are brain scans, highlighting potential scale if deployment succeeds.

November 19, 2025


Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an extended partnership with Cortechs.ai, a pioneer in quantitative neuroimaging solutions. Together, the companies will integrate Cortechs.ai’s advanced AI-enabled neuroimaging analytics directly into Philips’ MR systems [1], empowering clinicians with faster, more objective, and reproducible insights into brain health. The collaboration strengthens Philips’ leadership in precision neuro diagnostics, combining Philips’ next-generation MR technologies with Cortechs.ai’s AI-driven quantitative neuro imaging post processing software [1] to transform how neurological diseases are detected, monitored, and managed.


Combining complementary expertise for smarter brain imaging
Up to 25% [2] of all MR procedures are brain scans, and radiology departments face growing demand amid increasing staff shortages. At the same time, the number of patients with neurological conditions such as Alzheimer’s disease, multiple sclerosis (MS), and brain tumors continue to rise globally. Current MR interpretation of neurodegenerative diseases or neuro oncology cases depends heavily on visual assessment, introducing variability and requiring significant expertise and time in an already overloaded system.


Through this extended partnership, Philips and Cortechs.ai aim to deliver more standardized and data-driven imaging. By integrating quantitative analysis tools such as brain volumetrics, lesion quantification, and tumor tracking directly into the Philips MR imaging workflow [1], clinicians gain objective, numerical data alongside images – enabling faster, more consistent, and confident diagnoses.


Empowering clinicians with precision and speed
The integration of Cortechs.ai’s NeuroQuant® solutions for Alzheimer’s, MS and brain tumors within Philips’ Smart Reading environment – a cloud-based AI platform that combines imaging, reading, and reporting directly on the MR systems [1] – marks a major step toward precision neuroimaging.


With this integration, clinicians can automatically receive AI-generated quantitative reports within their standard MR workflow on the MR system or PACS, without adding extra steps for technologists. The zero-click process ensures quality-checked data and standardized outputs, helping radiologists interpret brain scans more objectively, faster and with greater confidence.


“By extending our partnership with Cortechs.ai, we are accelerating the transition to fully quantitative, AI-powered neuroimaging,” said Ioannis Panagiotelis, PhD, Business Leader, MRI, Philips. “This integration brings precision, reproducibility, and efficiency to neurological MR, helping clinicians make faster, more confident decisions for patients living with complex brain conditions.”


Driving productivity and improving care through AI
Philips is driving productivity and improving care through deep AI integration that tackles some of healthcare’s most pressing challenges – from workforce shortages to the growing demand for advanced diagnostics. By automatically generating quantitative reports within existing workflows, AI helps radiologists save time, improve consistency, and boost throughput. Objective numerical biomarkers enhance diagnostic accuracy, enabling more reproducible assessments and confident comparisons across time and sites. And by minimizing manual post-processing through automated, quality-controlled workflows, technologists can focus more on what matters most – delivering a better, more personalized patient experience.


“Cortechs.ai’s mission has always been to empower clinicians with actionable, quantitative insights,” said Kyle Frye, Chief Executive Officer, Cortechs.ai. “By combining our advanced neuro analytics with Philips’ leading MR platform and AI infrastructure, we’re making it easier to personalize brain care and track neurological changes with precision.”


Setting a new standard in precision neuro diagnostics
Cortechs.ai’s  NeuroQuant® solutions are already available on Philips Advanced Visualization Workspace. With this extended partnership, Philips reinforces its commitment to advancing the field of neurology – empowering healthcare providers to deliver better care for more people, in less time, with greater confidence.

[1] The integration of Cortechs.ai’s NeuroQuant® solutions on Philips MR systems via Smart Reading is works in progress and not available in any jurisdiction. Its future availability cannot be ensured.  NeuroQuant® is currently available via Advanced Visualization Workspace.
[2] Peter A. Rinck, Magnetic Resonance in Medicine – The Basics (14th ed., revised 2025), “MRI: Facts and Figures,” available online at https://www.magnetic-resonance.org/ch/21-01.html.
The opinions and clinical experiences presented herein are specific to the featured topic(s), are not linked to any specific patient and are for information purposes only. The medical experience(s) derived from these topics may not be predictive of all patients.  Individual results may vary depending on a variety of patient-specific attributes and related factors. Nothing in this presentation is intended to provide specific medical advice or to take the place of written law or regulations.

For further information, please contact:

Jayme Maniatis
Philips Global External Relations
Tel.: +1 (617) 894-8368
E-mail: jayme.maniatis@philips.com


Cortechs.ai
Tel.: +1 858 459 9700
E-mail: info@cortechs.ai  

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

About Cortechs.ai
Cortechs.ai is a leader in AI applications in radiology. Cortechs.ai uses cutting-edge technologies in medical imaging to revolutionize disease screening and early detection so patients can enjoy longer, healthier lives. The company develops and markets breakthrough medical device software that quantifies and tracks neurodegenerative diseases and assists in the detection of clinically significant cancer. Cortechs.ai’s industry-leading brain imaging software provides radiologists, neurologists, oncologists, and clinical researchers worldwide with a convenient and cost-effective way to quantify brain structures for assessing Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma, and other brain abnormalities. The company has FDA-cleared products for use in helping the diagnosis and follow-up of neurodegenerative and traumatic brain conditions, as well as prostate cancer. Please visit www.cortechs.ai for further information and follow us on Twitter, LinkedIn, and Facebook.

Attachment

• Clinician views Cortechs.ai neuroimaging analytics

FAQ

What did Philips (PHG) announce on November 19, 2025 about Cortechs.ai?

Philips announced an extended partnership to integrate Cortechs.ai’s NeuroQuant quantitative neuroimaging analytics into Philips MR workflows via Smart Reading.

How will the Philips PHG and Cortechs.ai integration affect MR workflow for clinicians?

The integration aims to deliver automated, zero-click quantitative reports (brain volumetrics, lesion quantification, tumor tracking) directly within the MR workflow or PACS to speed interpretation and improve consistency.

Is NeuroQuant already available on Philips MR systems as of November 19, 2025?

NeuroQuant is currently available on Philips Advanced Visualization Workspace; the Smart Reading integration on MR systems is a work in progress and not yet available in any jurisdiction.

What clinical areas do Cortechs.ai’s NeuroQuant solutions target for Philips (PHG)?

NeuroQuant solutions target Alzheimer’s disease, multiple sclerosis, and brain tumors with quantitative volumetrics and lesion/tumor tracking.

Will the PHG and Cortechs.ai integration require extra steps for technologists?

The announcement says the goal is a zero-click, automated process that delivers quality-checked quantitative reports without adding extra technologist steps.

What limitations did Philips (PHG) disclose about the Cortechs.ai integration timeframe?

Philips disclosed the Smart Reading integration is work in progress and its future availability cannot be ensured in any jurisdiction.